Highland Capital Management (Texas)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-35,500
Closed -$3.6M 357
2017
Q3
$3.6M Sell
35,500
-58,100
-62% -$6.22M 0.16% 117
2017
Q2
$9.38M Buy
93,600
+42,600
+84% +$4.58M 0.4% 51
2017
Q1
$6.17M Buy
+51,000
New +$6.26M 0.31% 81
2016
Q1
Sell
-105,291
Closed -$7.31M 287
2015
Q4
$7.31M Buy
+105,291
New +$8.58M 0.23% 120
2014
Q3
Sell
-34,611
Closed -$3.71M 288
2014
Q2
$3.71M Buy
+34,611
New +$2.41M 0.14% 110

Other funds holding GWPH

Highland Capital Management (Texas)'s GWPH Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 35,500 shares — an estimated $3.6M sold.

Highland Capital Management (Texas) first reported a position in GWPH in Q2 2014 and held it in 5 quarters. The position peaked at $9.38M in Q2 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

  • Highland Capital Management (Texas) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 35,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $3.6M.
  • Highland Capital Management (Texas) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 5 quarters.
  • Highland Capital Management (Texas)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.38M in Q2 2017.
  • 204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.